LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $92,149,072
Key CONT_AWD_75N91021F00013_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 8 days before this system saw it. One version on record.
Cite this row
b20caa43baa0e700e27f98359ff3cc997b16127cd23c79a620322bbbfd7d5081The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $92,149,072 | first version | August 30, 2021 | August 28, 2026 | 2026-09-05T00:54:28Z | historical sweep | b20caa43baa0 |
Archived copy
https://web.archive.org/web/20261010111436/https://www.usaspending.gov/award/CONT_AWD_75N91021F00013_7529_75N91019D00024_7529 found, made by someone else, October 10, 2026
What the amount is made of
14 recorded actions, so the amount is the award's current total across all of them. 10 of them obligated money. Measured 2026-10-13, when USAspending reported a total obligation of $98,565,259.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| September 22, 2026 | P00013 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$6,416,187 | CHILDHOOD CANCER RESEARCH AND CCDSF |
| August 28, 2026 | P00012 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$11,231,388 | CHILDHOOD CANCER RESEARCH AND CCDSF |
| December 16, 2025 | P00011 | EXERCISE AN OPTION | +$16,060,629 | CHILDHOOD CANCER RESEARCH AND CCDSF |
| September 10, 2025 | P00010 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$2,266,604 | CHILDHOOD CANCER RESEARCH AND CCDSF |
| July 17, 2025 | P00009 | OTHER ADMINISTRATIVE ACTION | no money | CHILDHOOD CANCER RESEARCH AND CCDSF |
| December 20, 2024 | P00008 | CHANGE ORDER | +$15,630,886 | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 03 IN THE AMOUNT OF $15,630,886.00. ARTICLES B.2., B.3., B.4., F.1., AND G.3. ARE REVISED ACCORDINGLY. |
| September 26, 2024 | P00007 | CHANGE ORDER | +$1,500,000 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIODS OF PERFORMANCE FOR OPTION 01 AND 02 AND INCREASE THE COST PLUS FIXED FEE CEILING OF OPTION 02 FROM $15,304,252 BY $1,500,000 TO $16,804,252. |
| December 19, 2023 | P00006 | EXERCISE AN OPTION | +$15,304,252 | THIS IS A BILATERAL MODIFICATION TO EXERCISE OPTION 2 IN THE AMOUNT OF $15,304,242 |
| July 7, 2023 | P00005 | OTHER ADMINISTRATIVE ACTION | no money | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| January 12, 2023 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| July 28, 2022 | P00003 | EXERCISE AN OPTION | +$15,219,907 | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| March 2, 2022 | P00002 | OTHER ADMINISTRATIVE ACTION | no money | ENABLING NCI CLINICAL & RESEARCH DATA SHAR |
| December 16, 2021 | P00001 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | −$1 | ENABLING NCI CLINICAL & RESEARCH DATA SHARING |
| August 30, 2021 | base | not on file | +$14,935,407 | ENABLING NCI CLINICAL & RESEARCH DATA SHARING |
Last refreshed November 4, 2026 at 2:31 PM UTC.